Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ACI FormulationsDHA:ACIFORMULA +1.42%88 EBITDA Margin % is 13.39% as of Mar. 2026, which is 11% above its 10-year median of 12.04. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 88/100 and a GF Value™ of BDT149.51 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 248 Agriculture companies, ACI Formulations ranks better than 68.95% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. ACI Formulations's EBITDA for the
three
months ended in Mar. 2026 was BDT182 Mil. ACI Formulations's Revenue for the
three
months ended in Mar. 2026 was BDT1,360 Mil. Therefore, ACI Formulations's EBITDA margin for the quarter that ended in Mar. 2026 was 13.39%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
ACI Formulations EBITDA Margin % Related Terms
ACI Formulations EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for ACI Formulations's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACIFORMULA vs CTVA, CF, MOS: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, ACI Formulations's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACI Formulations EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, ACI Formulations's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where ACI Formulations's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACI Formulations (DHA:ACIFORMULA) has a EBITDA Margin % of 13.39% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ACI Formulations and its competitors. This is 11% above median its historical median of 12.04. Over the past decade, ACI Formulations' EBITDA Margin % has ranged from 10.07 to 15.49. According to the industry distribution chart, ACI Formulations ranks #77 out of 248 companies in the Agriculture industry, placing it in the top 31%.
Is ACI Formulations' EBITDA Margin % too high?
ACI Formulations' current EBITDA Margin % of 13.39% is 11% above median its 10-year median of 12.04. Over the past 10 years, this metric has ranged from a low of 10.07 to a high of 15.49. The Agriculture industry median EBITDA Margin % is 9.63. ACI Formulations' value of 13.39% is 39% above this industry median. Based on the distribution chart, ACI Formulations ranks #77 out of 248 companies in the Agriculture industry, which is above the industry midpoint. Overall, ACI Formulations has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, ACI Formulations ranks #77 out of 248 companies for EBITDA Margin %. This puts ACI Formulations in the upper half of its industry. The industry median EBITDA Margin % is 9.63. ACI Formulations' value of 13.39% is 39% above this benchmark. Historically, ACI Formulations' own EBITDA Margin % has ranged from 10.07 to 15.49 over the past decade. While the company's 10-year median is 12.04 vs. the industry median of 9.63, ACI Formulations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.63, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACI Formulations's current EBITDA Margin % of 13.39% is 39% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ACI Formulations and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACI Formulations's current EBITDA Margin % is 13.39%, which is 11% above median its own 10-year median of 12.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT149.51, compared to a current price of BDT172.00 — trading 15% above its estimated fair value. The current EBITDA Margin % is 13.39%, which is 11% above median its 10-year median of 12.04 and 39% above the Agriculture industry median of 9.63. ACI Formulations' overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current EBITDA Margin % is 13.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?
Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued.
The current stock price of BDT172.00 is trading 15% above its estimated GF Value™ of BDT149.51.
GuruFocus considers ACI Formulations to be Modestly Overvalued.
Key valuation signals for DHA:ACIFORMULA:
EBITDA Margin %: 13.39% (11% above median its 10-year median of 12.04)
GF Value™: BDT149.51 vs. price of BDT172.00 (15% above fair value)
Industry Position: 39% above the Agriculture median (#77 of 248)
No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score
Get the complete analysis for DHA:ACIFORMULA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACIFORMULA has been successfully added to your 
